microdosing semaglutides Americans are obesity drugs, driven by 'thin is in' blitz Standard Dose vs Microdose GLP-1:

Retrieved from Purnamawati, S., Indrastuti, N., Danarti, R., & Saefudin, T

Abstract Introduction Clinical trials have demonstrated greater glycemic control and weight loss with once-weekly (OW) semaglutide versus other anti-diabetes medications, including sodium-glucose co-transporter 2 inhibitors (SGLT2is) in adults with type 2 diabetes (T2D), yet real-world evidence is limited

The inclusion in another largely unexplored dimension, as the potential role it may have on the gut-microbiota-brain axis is also interesting

2018 Apr 3;27(4):740-756

At the same time, a substantial proportion of uptake reflected switching from injectable AOM GLP-1-based medications, particularly AOM tirzepatide and injectable AOM semaglutide

Use toothpaste with fluoride